It is now common practice in the pharmaceutical industry to use molecular d
iversity selection methods. With the advent of high throughput screening an
d combinatorial chemistry, compounds must be rationally selected from datab
ases of hundreds of thousands of compounds to be tested for several biologi
cal activities. We explore the differences between diversity and representa
tivity. Validation runs were made for different diversity selection methods
(such as the MaxMin function), several representativity techniques (select
ion of compounds closest to centroids of clusters, Kohonen neural networks,
nonlinear scaling of descriptor values), and various types of descriptors
(topological and 3D fingerprints) including some validated whole-molecule n
umerical descriptors that were chosen for their correlation with biological
activities. We find that only clustering based on fingerprints or on whole
-molecule descriptors gives results consistently superior to random selecti
on in extracting a diverse set of activities from a file with potential dru
g molecules. The results further indicate that clustering selection from fi
ngerprints is biased toward small molecules, a behavior that might partly e
xplain its success over other types of methods. Using numerical descriptors
instead of fingerprints removes this bias without penalising performance t
oo much.